|
|
Volumn 46, Issue 5, 2006, Pages 650-655
|
|
New drugs: rasagiline mesylate, conivaptan hydrochloride, and sunitinib malate.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTIPARKINSON AGENT;
BENZAZEPINE DERIVATIVE;
CONIVAPTAN;
INDAN DERIVATIVE;
INDOLE DERIVATIVE;
MONOAMINE OXIDASE INHIBITOR;
PYRROLE DERIVATIVE;
RASAGILINE;
SUNITINIB;
VASOPRESSIN RECEPTOR;
ARTICLE;
DRUG ANTAGONISM;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
GASTROINTESTINAL STROMAL TUMOR;
HUMAN;
HYPONATREMIA;
UNITED STATES;
ANTINEOPLASTIC AGENTS;
ANTIPARKINSON AGENTS;
BENZAZEPINES;
DRUG APPROVAL;
GASTROINTESTINAL STROMAL TUMORS;
HUMANS;
HYPONATREMIA;
INDANS;
INDOLES;
MONOAMINE OXIDASE INHIBITORS;
PYRROLES;
RECEPTORS, VASOPRESSIN;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 33750737359
PISSN: 15443191
EISSN: None
Source Type: Journal
DOI: 10.1331/1544-3191.46.5.650.Hussar Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
